Trust is the real currency of medicine

FOR nearly four decades since the passage of the Generics Law in 1988, the conversation on medicines has always revolved around affordability. Policymakers pushed for wider access, doctors sought cheaper treatment options, and pharmacies filled their shelves with lower-cost alternatives. But as the pharmaceutical market grows more complex, a new conversation is emerging: price alone is not enough. What ultimately sustains public health is trust. That theme surfaced sharply during a recent Senate